| Rheumatoid Arthritis |
1 |
1 |
| Exercise |
0 |
0.77 |
| Pregnancy |
0 |
0.66 |
| Biologic Therapy |
0 |
0.58 |
| Disease-Modifying Antirheumatic Drugs |
0 |
0.52 |
| COVID-19 |
0 |
0.5 |
| Healthcare and Medical Technology |
0 |
0.4 |
| Arthritis |
0 |
0.36 |
| Artificial Intelligence |
0 |
0.36 |
| Remission |
0 |
0.31 |
| Diet |
0 |
0.21 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.21 |
| Biomarker |
0 |
0.15 |
| Muscle |
0 |
0.15 |
| Alzheimer Disease |
0 |
0.14 |
| Cerebrovascular Accident |
0 |
0.12 |
| Arthralgia |
0 |
0.11 |
| Cardiovascular Risk Management |
0 |
0.11 |
| Multi-Infarct Dementia |
0 |
0.11 |
| Obesity |
0 |
0.11 |
| Pain Management |
0 |
0.11 |
| Cardiovascular disease |
0 |
0.1 |
| Clinical Guidelines |
0 |
0.1 |
| Dementia |
0 |
0.1 |
| Pain |
0 |
0.1 |
| Rheumatic Disease |
0 |
0.1 |
| Premature Birth |
0 |
0.07 |
| Genomic Medicine |
0 |
0.06 |
| Myocardial Infarction (MI) |
0 |
0.06 |
| Social Determinants of Health |
0 |
0.06 |
| Toxicology |
0 |
0.06 |
| Tropical Diseases |
0 |
0.06 |
| Vasculitis |
0 |
0.06 |